全文获取类型
收费全文 | 656篇 |
免费 | 40篇 |
出版年
2023年 | 4篇 |
2022年 | 23篇 |
2021年 | 27篇 |
2020年 | 29篇 |
2019年 | 82篇 |
2018年 | 36篇 |
2017年 | 28篇 |
2016年 | 29篇 |
2015年 | 29篇 |
2014年 | 44篇 |
2013年 | 77篇 |
2012年 | 57篇 |
2011年 | 60篇 |
2010年 | 32篇 |
2009年 | 30篇 |
2008年 | 24篇 |
2007年 | 18篇 |
2006年 | 19篇 |
2005年 | 8篇 |
2004年 | 5篇 |
2003年 | 5篇 |
2002年 | 7篇 |
2001年 | 1篇 |
2000年 | 2篇 |
1999年 | 2篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1993年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1986年 | 1篇 |
1976年 | 1篇 |
1973年 | 2篇 |
排序方式: 共有696条查询结果,搜索用时 31 毫秒
31.
Masoud Ghiasian Forough Khamisabadi Nejat Kheiripour Manouchehr Karami Rasool Haddadi Ali Ghaleiha Babak Taghvaei Seyed Sajad Oliaie Mohammadjavad Salehi Pouria Samadi Akram Ranjbar 《Journal of biochemical and molecular toxicology》2019,33(12)
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the nerve cells, resulting in neurological disorders. Oxidative stress, free radicals, and neuritis have important roles in MS pathogenesis. Here, we aim to evaluate the effect of crocin on inflammatory markers, oxidative damage, and deoxyribonucleic acid (DNA) damage in the blood of patients with MS. A total of 40 patients were divided into two groups, drug and placebo‐treated groups, using random assignment. Participants of the intervention and control groups received two crocin capsules or placebo per day for 28 days, respectively. Findings revealed a significant decrease in the level of important pathogenic factors in MS, including lipid peroxidation, DNA damage, tumor necrosis factor‐alpha, and interleukin 17 as well as a significant increase in the total antioxidant capacity in the serum of patients treated with crocin compared with the placebo group. Our results suggest the beneficial and therapeutic effects of crocin in MS. 相似文献
32.
33.
34.
35.
Elaheh Esmaeili Masoud Soleimani Mohammad Adel Ghiass Shadie Hatamie Saeed Vakilian Mahsa Soufi Zomorrod Negar Sadeghzadeh Manouchehr Vossoughi Simzar Hosseinzadeh 《Journal of cellular physiology》2019,234(8):13617-13628
While the differentiation factors have been widely used to differentiate mesenchymal stem cells (MSCs) into various cell types, they can cause harm at the same time. Therefore, it is beneficial to propose methods to differentiate MSCs without factors. Herein, magnetoelectric (ME) nanofibers were synthesized as the scaffold for the growth of MSCs and their differentiation into neural cells without factors. This nanocomposite takes the advantage of the synergies of the magnetostrictive filler, CoFe2O 4 nanoparticles (CFO), and piezoelectric polymer, polyvinylidene difluoride (PVDF). Graphene oxide nanosheets were decorated with CFO nanoparticles for a proper dispersion in the polymer through a hydrothermal process. After that, the piezoelectric PVDF polymer, which contained the magnetic nanoparticles, underwent the electrospun process to form ME nanofibers, the ME property of which has the potential to be used in areas such as tissue engineering, biosensors, and actuators. 相似文献
36.
Masoud Najafi Eniseh Salehi Bagher Farhood Maryam Shabani Nashtaei Nasser Hashemi Goradel Neda Khanlarkhani Zeinab Namjoo Keywan Mortezaee 《Journal of cellular physiology》2019,234(3):2356-2372
Melatonin is a multifunctional hormone that has long been known for its antitumoral effects. An advantage of the application of melatonin in cancer therapy is its ability to differentially influence tumors from normal cells. In this review, the roles of melatonin adjuvant therapy in human cancer are discussed. Combination of melatonin with chemotherapy could provide synergistic antitumoral outcomes and resolve drug resistance in affected patients. This combination reduces the dosage for chemotherapeutic agents with the subsequent attenuation of side effects related to these drugs on normal cells around tumor and on healthy organs. The combination therapy increases the rate of survival and improves the quality of life in affected patients. Cancer cell viability is reduced after application of the combinational melatonin therapy. Melatonin does all these functions by adjusting the signals involved in cancer progression, re-establishing the dark/light circadian rhythm, and disrupting the redox system for cancer cells. To achieve effective therapeutic outcomes, melatonin concentration along with the time of incubation for this indoleamine needs to be adjusted. Importantly, a special focus is required to be made on choosing an appropriate chemotherapy agent for using in combination with melatonin. Because of different sensitivities of cancer cells for melatonin combination therapy, cancer-specific targeted therapy is also needed to be considered. For this review, the PubMed database was searched for relevant articles based on the quality of journals, the novelty of articles published by the journals, and the number of citations per year focusing only on human cancers. 相似文献
37.
Vahid Hosseini Christian Dani Mohammad Hossein Geranmayeh Fatemeh Mohammadzadeh Saeed Nazari Soltan Ahmad Masoud Darabi 《Journal of cellular physiology》2019,234(6):8040-8054
The Wnt signaling pathway consists of various downstream target proteins that have substantial roles in mammalian cell proliferation, differentiation, and development. Its aberrant activity can lead to uncontrolled proliferation and tumorigenesis. The posttranslational connection of fatty acyl chains to Wnt proteins provides the unique capacity for regulation of Wnt activity. In spite of the past belief that Wnt molecules are subject to dual acylation, it has been shown that these proteins have only one acylation site and undergo monounsaturated fatty acylation. The Wnt monounsaturated fatty acyl chain is more than just a hydrophobic coating and appears to be critical for Wnt signaling, transport, and receptor activation. Here, we provide an overview of recent findings in Wnt monounsaturated fatty acylation and the mechanism by which this lipid moiety regulates Wnt activity from the site of production to its receptor interactions. 相似文献
38.
Keywan Mortezaee Ensieh Salehi Hanifeh Mirtavoos-mahyari Elahe Motevaseli Masoud Najafi Bagher Farhood Rhonda J. Rosengren Amirhossein Sahebkar 《Journal of cellular physiology》2019,234(8):12537-12550
Cancer incidences are growing and cause millions of deaths worldwide. Cancer therapy is one of the most important challenges in medicine. Improving therapeutic outcomes from cancer therapy is necessary for increasing patients’ survival and quality of life. Adjuvant therapy using various types of antibodies or immunomodulatory agents has suggested modulating tumor response. Resistance to apoptosis is the main reason for radioresistance and chemoresistance of most of the cancers, and also one of the pivotal targets for improving cancer therapy is the modulation of apoptosis signaling pathways. Apoptosis can be induced by intrinsic or extrinsic pathways via stimulation of several targets, such as membrane receptors of tumor necrosis factor-α and transforming growth factor-β, and also mitochondria. Curcumin is a naturally derived agent that induces apoptosis in a variety of different tumor cell lines. Curcumin also activates redox reactions within cells inducing reactive oxygen species (ROS) production that leads to the upregulation of apoptosis receptors on the tumor cell membrane. Curcumin can also upregulate the expression and activity of p53 that inhibits tumor cell proliferation and increases apoptosis. Furthermore, curcumin has a potent inhibitory effect on the activity of NF-κB and COX-2, which are involved in the overexpression of antiapoptosis genes such as Bcl-2. It can also attenuate the regulation of antiapoptosis PI3K signaling and increase the expression of MAPKs to induce endogenous production of ROS. In this paper, we aimed to review the molecular mechanisms of curcumin-induced apoptosis in cancer cells. This action of curcumin could be applicable for use as an adjuvant in combination with other modalities of cancer therapy including radiotherapy and chemotherapy. 相似文献
39.
40.
Masoud Najafi Nasser Hashemi Goradel Bagher Farhood Eniseh Salehi Somaye Solhjoo Heidar Toolee Ebrahim Kharazinejad Keywan Mortezaee 《Journal of cellular physiology》2019,234(5):5700-5721
Tumor microenvironment (TME) is a host for a complex network of heterogeneous stromal cells with overlapping or opposing functions depending on the dominant signals within this milieu. Reciprocal paracrine interactions between cancer cells with cells within the tumor stroma often reshape the TME in favor of the promotion of tumor. These complex interactions require more sophisticated approaches for cancer therapy, and, therefore, advancing knowledge about dominant drivers of cancer within the TME is critical for designing therapeutic schemes. This review will provide knowledge about TME architecture, multiple signaling, and cross communications between cells within this milieu, and its targeting for immunotherapy of cancer. 相似文献